Browsed by
Tag: Parents

KB Collaborates on Two New Sun Safety Research Projects

KB Collaborates on Two New Sun Safety Research Projects

Childhood is a critical period for reducing the risk of skin cancer later in life. Sunburns in childhood are the primary modifiable risk factor for melanoma and keratinocyte (basal and squamous cell) skin cancers. The U.S. Preventive Services Task Force recommends counseling children and their parents about minimizing exposure to ultraviolet radiation (UVR) for youths with fair skin types to reduce their risk for skin cancer. All cancer-focused professional agencies recommend sun safety for children. Despite the risks, engagement in regular sun protection among children is low and prevalence of excessive UVR exposure and sunburn is high, with more than 80% of children experiencing at least one sunburn in the past summer.

Klein Buendel’s Director of Research, Dr. David Buller, is collaborating with Dr. Sharon Manne (Principal Investigator) from Rutgers University on two new skin cancer prevention research projects funded by the National Cancer Institute.

Young children under age 7 have less capacity to manage their sun safety, leaving parents carrying the primary responsibility for child sun protection. Child engagement in sun protection is influenced by both individual and interpersonal parent factors. Individual factors include parent sun safety knowledge and attitudes about child sun safety such as perceived risk for the child developing skin cancer, barriers to implementing child sun protection, and confidence for implementing child sun safety. Interpersonal factors include family norms, parent practices for child sun protection, and planning for child sun safety. 

Despite the importance of improving sun safety behaviors in children, behavioral intervention research focused on supporting parent management of child sun safety is limited. Parents play a pivotal role in managing their child’s sun safety across settings and helping their child develop good sun safety habits. Even among motivated parents, effective parenting behavior for child sun protection can be challenging. 

This research project will deliver a parent-focused sun safety intervention using Facebook. The platform is very popular with parents and should harness positive influences of user-generated messages from other parents of similar-age children. The research team developed and conducted a pilot study of a Facebook group intervention, called Playing It Safe in the Sun (Playing It Safe), that improved sun protection and weekday UVR exposure. 

The goalof this study is to test the efficacy of a 12-week Playing It Safe intervention against an active control condition, Healthy Kids health education intervention without sun safety content, to improve sun safety among children aged 3 to 7. In Phase 1, the researchers will enhance Playing It Safe by increasing its focus on child skin cancer risk, child sun safety knowledge, and managing barriers, and add email messages to foster greater engagement with the intervention. In Phase 2, a randomized controlled trial will be conducted with 720 parents of children aged 3 to 7 recruited from social media ads. This work will advance our knowledge about parent-focused interventions to improve child sun safety using social media channels. 

This research project was awarded to Rutgers University by the National Cancer Institute (CA299354; Dr. Sharon Manne, Principal Investigator). Dr. David Buller from Klein Buendel is a Co-Investigator.

In middle childhood (defined as ages 8-12 or the “tween” years), sun protection declines and UVR exposure and sunburn increase. Although parents remain responsible for the child’s sun safety, effective parenting during the tween years involves scaffolding or supporting the child in establishing sun safety behaviors and developing strategies to implement them.

Despite the importance of improving sun protection during middle childhood, behavioral intervention research involving parents is limited. However, the existing parent-focused sun safety intervention research has found small but positive effects on child sun safety.

This new research project will deliver a sun safety intervention to parents of children aged 8 to 12, using private Facebook groups. As an intervention channel, social media have the potential to reach many families at risk for a variety of diseases while harnessing influences from their peers (parents of similarly aged children). The research team will adopt the Integrative Behavioral Model and the concepts from Self-Determination Theory to teach autonomy-support parenting skills (communication and planning) and foster positive attitudes about child sun protection (skin cancer risk, managing barriers), norms (peer and family norms), and agency (self-efficacy to implement child sun protection).

The goal of the project is to evaluate the Sun Safe Families Facebook intervention against an active control condition, called the Healthy Families intervention (without sun safety content), to improve sun safety among children aged 8 to 12. A  randomized controlled trial will be conducted enrolling 690 parent-child dyads recruited by social media advertising and internet survey panels. 

This research project was awarded to Rutgers University by the National Cancer Institute (CA299354; Dr. Sharon Manne, Principal Investigator). Dr. David Buller from Klein Buendel is a Co-Investigator. 

Launch of the PASS Project

Launch of the PASS Project

Dr. David Buller, Klein Buendel Director of Research, has launched a new sun safety research project for Kindergarten-6 schools and parents. The goal of this study (Parents and Schools for Sun Safety; PASS) is to establish the feasibility of a parent intervention that can be delivered by schools to instruct parents and students in sun protection and, ultimately, skin cancer prevention by establishing lifelong health habits.

Policy and instruction on sun protection in U.S. schools are recommended by the Centers for Disease Control and Prevention and Surgeon General to reduce students’ lifetime risk for skin cancer. With advocacy efforts from the American Society for Dermatologic Surgery Association, more than half of U.S. states (n=29) and the District of Columbia (DC) have passed laws on sun protection of children in public schools. In our past research on implementation of school sun safety policy, many school principals and teachers engaged in communication about sun safety with parents. Moreover, parents who reported receiving the sun safety messages from schools increased sun protection behavior for their children compared to parents who did not recall receiving these messages. However, there are few evidence-based parent-focused interventions available to schools to help themcomply with the state sun safety legislation.

This Phase I feasibility study will consist of a needs analysis and technology assessment by parents and staff in the 29 states and DC with sun safety legislation, production of a PASS prototype, and a pilot study evaluating the prototype’s feasibility. In the Parent Perspectives survey, 300 parents of children in grades Kindergarten-6 will complete the needs analysis by completing a survey on sun protection behaviors, skin type, barriers to sun protection, PASS content, and preferences for content delivery. In the technology assessment, 150 school staff (principals, teachers, and other staff) will complete the Barriers & Supports survey answering questions about communications and technology at school, competing priorities for implementation, and barriers to engaging with PASS.

A prototype of one module of the PASS program promoting sun safety in family outdoor activities outside of school will be produced, containing a video introduction, video parent testimonials, interactive activities, knowledge checks, and collaborative family activity. It will be tested with 40 parents of children in grades K-6 over four weeks. Parents will complete pretest and posttest surveys measuring students’ sun protection behavior, parents’ knowledge, self-efficacy, barriers, and motivation for child sun safety, and acceptability and usability of the prototype. Usage of the prototype will be recorded to assess parent engagement. A multidisciplinary Expert Advisory Board will review Phase I research protocols and the PASS prototype and advise on markers of PASS feasibility such as user accessibility; prototype acceptability, usability, and engagement; and evidence of collaborative family activity.

This research is sponsored by a Phase I SBIR grant from the Centers for Disease Control and Prevention (DP006971; Dr. David Buller, Principal Investigator). Dr. Buller’s collaborators include Mary Buller from Klein Buendel. The PASS prototype will be programmed by the Technology Team at Klein Buendel.

TeenVac to Improve HPV Vaccine Uptake in Adolescent Boys

TeenVac to Improve HPV Vaccine Uptake in Adolescent Boys

Human papillomavirus (HPV) vaccine uptake remains below the Healthy People 2030 goal of 80% series completion in the United States. Parental concerns about the efficacy and safety of the vaccine remain and may be addressed by digital interventions tailored to their concerns.

Dr. W. Gill Woodall, Klein Buendel Senior Scientist, led a large study supported by the National Cancer Institute to increase HPV vaccination among adolescent boys . The results of the study have been published in the Journal of Adolescent Health. Specifically, the paper reports on the purpose, methods, and effectiveness of TeenVac, a mobile app to encourage HPV vaccination in families with adolescent boys.

A randomized trial was conducted between May 2019 and December 2020, testing the mobile web app (teenvac.org) that encouraged HPV vaccination for parents and sons aged 11–14 years old. Parents and 209 adolescent sons were randomized to receive either the TeenVac app or the Centers for Disease Control and Prevention (CDC) HPV vaccination pamphlet online. Participants had access to the TeenVac app or the CDC pamphlet for the 9-month study duration. Adolescent sons’ vaccination records were collected from the state vaccine registry at the end of the study.

Intent-to-treat and web usage analyses were conducted. Intent-to-treat analyses found that adolescent sons of parents randomized to the TeenVac app were significantly more likely to complete the HPV vaccination series than those randomized to the CDC pamphlet group. Web usage analysis confirmed that the TeenVac group parents who used the web app were significantly more likely to have sons complete the HPV vaccination series than those in the CDC pamphlet group.

The TeenVac app meaningfully impacted HPV vaccine series completion, particularly among parents who used the web app. The results provide further evidence that digital interventions can improve vaccine uptake when focused on parents’ and sons’ vaccine-related concerns.

This research was supported by a grant from the National Cancer Institute (CA210125; Dr. W. Gill Woodall, Principal Investigator). Dr. Woodall’s coauthors include Dr. Gregory Zimet from Indiana University; Dr. Alberta Kong, Dr. Lance Chilton, and Dr. Tamar Ginossar from the University of New Mexico; Jennyfer Reither from Denver Health Hospital; and Dr. David Buller, Lila Martinez, Marita Brooks, and Noah Chirico from Klein Buendel.

Results of the Pinpoint Project

Results of the Pinpoint Project

The Pinpoint web app was created and evaluated by Klein Buendel in collaboration with HPC International through a grant funded by the National Institute on Minority Health and Health Disparities (MD010746; Dr. Valerie Myers, Principal Investigator). Designed for adolescents aged 13-17, the Pinpoint web app provides education on communication strategies and sickle cell disease (SCD) care management. Pinpoint includes a pain assessment tool, vocabulary game, body scanner reflection, and educational self-disclosure activity. It was developed as an interactive gaming web app for use on smartphones, tablets, and desktop computers. Learning Buddies were added to act as a guide for the teen in the app to explain each activity and feature with text and voiceover. There are two Learning Buddy characters to choose from, each of whom had their own fictional story about living with SCD. Learning Buddies are customizable, allowing teen participants to choose clothing, hair style, and skin tone upon registering for the app. For each activity the teens participate in, points can be earned to unlock additional customization options, including hats, jewelry, and more hairstyles and clothing options. A Self-Disclosure Stories section was also added to the web app. This consists of stories from real people, including children, young adults, and older adults living with SCD.

The fully developed app was used to interview clinicians to evaluate content and clinical meaningfulness (n=10). Additionally, adolescents (n=11), aged 13-17, with SCD participated in usability testing to evaluate the user interface, ease of use, and perceived barriers. Both clinicians and teens participating in the usability study were encouraged to go through the app on their own while sharing their screen and describing aloud their thoughts and impressions of the app. They were then guided to specific parts of the app (such as the vocabulary game, self-disclosure activity, Pain Assessment Tool, Body Scanner Reflection, and Learning Buddies) to review.

Overall, clinicians believed the app content was meaningful and engaging, would help their patients better identify SCD pain and would help them better treat their patients’ pain. Clinicians also said they would encourage SCD patients to use the app. Teen participants in the usability testing found the app to be easy to use and understand. They enjoyed the interactivity of the games, found the Learning Buddy to be interesting and relatable, and liked that they could share the information recorded on the pain assessment tool with caregivers and healthcare providers by text or email.

In a subsequent randomized, stepped-wedge trial, the app was tested with 13–17-year-olds with SCD and one of their parents to evaluate changes in knowledge acquisition for communicating about pain. Community-based recruitment strategies were used. This involved attending SCD conferences, creating relationships with community-based organizations (such as sickle cell associations, sickle cell camps, libraries, Boys and Girls clubs, YMCAs, and clinics), online recruitment (such as Facebook/Reddit ads and posting in SCD-specific groups on Facebook/Reddit), partnering with companies that specialize in recruiting for SCD research, and snowball recruitment. Through these efforts, 24 teen/parent dyads were successfully recruited and randomly assigned to study group.

Both teens and their parent took a survey every 4 weeks for 12-16 weeks and used the app for 4-12 weeks, depending on which arm of the study they were assigned. Parents and teens randomized into Arms 1-3 took surveys every 4 weeks for 12 weeks and downloaded the Pinpoint app at Baseline (Arm 1; used the app for 12 weeks), 4 Weeks (Arm 2; used the app for 8 weeks), or 8 Weeks (Arm 3; used the app for 4 weeks), while participants in Arm 4 took surveys every 4 weeks for 16 weeks and downloaded the Pinpoint app at 12 Weeks (used the app for 4 weeks). Surveys were completed during a virtual check-in via Zoom with a member of the study staff. There was 100% retention of both parents and adolescents throughout the intervention for follow-up surveys.

Adolescents reported on pain interference, peer relationships, physical stress experiences, psychological stress experiences, pain behavior, pain quality, experiences with providers, family relationships, communication, and personal experiences with the SCD. Parents were assessed on disease knowledge, family relationships, family communication, and their experiences managing their child’s SCD. The adolescents were 92% African American, 8% Hispanic, 54% male, and the mean age was 14.8. SCD was not a new disease for any of the participants. The parents were 93% African American, 4% Hispanic, 92% female, and the mean age was 44.9. The small sample size prohibits the investigators from evaluating changes between groups, though summary statistics at each time point were created and reviewed.

In the final surveys, adolescents also reported on the usability of the web app:

At the baseline and the final survey time points, adolescents reported on communication and SCD pain management:

Lastly, web app usage data was collected. From the 24 adolescents randomized, 34 pain reports were entered by 16 unique users (67%) within the app. Of those pain reports recorded, 20 (59%) were shared with their parent or health care provider via the app.

Pinpoint is available to individuals and medical providers. To learn more about the Pinpoint app, check out the video tutorial or visit HPC International.

EZPreemie Study Protocol

EZPreemie Study Protocol

A research team from The Ohio State University, Rush University, Nationwide Children’s Hospital, and Klein Buendel has published a paper describing a 5-year research project to develop and evaluate a technology-based, widely accessible, and effective form of behavioral parent training (BPT) delivery to address the unmet and unique needs of parents of very preterm children.

As presented in the paper published in BMJ Open, children born very preterm (gestational age <32 weeks) are twice as likely to demonstrate behavior problems such as aggression, non-compliance, temper tantrums and irritability compared with their term-born peers. While BPT is a gold standard for prevention and treatment of childhood problem behaviors, there are limited accessible and effective BPT interventions for families with children born very preterm. The paper describes a multi-center, randomized controlled protocol for a factorial design trial evaluating the independent and combined effects of the ezParent BPT intervention plus brief, weekly coaching calls on parent and child outcomes for families with toddlers born very preterm.

The BMJ Open paper details the study design, aims, intervention, measures, analysis plans, and procedures of the study which will employ a 2×2 factorial randomized design. Parents (n=220) of children aged 20–30 months corrected age who were born very preterm (<32 weeks) will be recruited from two large metropolitan Neonatal Intensive Care Unit follow-up clinics and randomized to one of four conditions: (1) ezParent (2) ezParent + coach, (3) active control or (4) active control + coach. A web-based app will provide behavioral training through brief videos, interactivity, reflection questions, and assessments. Data on parenting and child behavior outcomes will be obtained from all participants at baseline and 3, 6 and 12 months for program evaluation.

This research is being led by Dr. Susan Breitenstein from The Ohio State University (OSU) and Dr. Michelle Greene of Rush University (Multiple Principal Investigators). It is funded by a grant from The Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institute of Health (HD104072). Additional co-authors on this publication include Dr. Michael Schoeny and Dr. Kousiki Patra from Rush University; Dr. Sarah Keim from Nationwide Children’s Hospital and OSU; Dr. Mary Lauren Neel from Nationwide Children’s Hospital; Ms. Shea Smoske from OSU; and Ms. Julia Berteletti from Klein Buendel.


ezPreemie Project

ezPreemie Project

Today, 80-90% of very preterm infants survive. However, preterm birth alters the development of the prefrontal cortex, the brain region heavily involved in behavior regulation and inhibition. This places children born very preterm at high risk for developmental delays and behavioral problems.

Early prevention and intervention can interrupt the development of problem behaviors, reduce active problem behaviors and improve functioning for children and families. Behavioral parent training (BPT) is a gold standard for prevention and treatment of child behavior problems. BPT teaches child management skills and positive parenting strategies. Little is known about the use and effects of BPT programs for former very preterm infants with their unique medical, developmental, and psychological risk profiles.

A research team from Ohio State University, Rush University, Nationwide Children’s Hospital, and Klein Buendel is launching a 5-year research project to develop and evaluate a technology-based, widely accessible, and effective form of BPT delivery to address the unmet and unique needs of parents of very preterm children. The app will be tested alone and in combination with specialized coaching. The project is called “Parent Training for Parents of Toddlers Born Very Premature.” It is being led by Dr. Susie Breitenstein from Ohio State University (OSU) and Dr. Michele Greene from Rush University (Multiple Principal Investigators). The project is funded by The Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health (HD104072).

The research project will design and develop a web-based app, similar to one developed previously by Dr. Breitenstein and her team, called ezParent. ezParent was designed for parents of children ages 2-6 years. It provides behavioral training through brief videos, interactivity, reflection questions, and assessments to parents of young children. The new iteration of ezParent, ezPreemie, will assess the independent and combined effects of ezParent and coaching calls on parent and child outcomes in families with very preterm infants.

Dr. Breitenstein, PhD, RN, FNAP, FAAN, is an Associate Professor, Assistant Dean for Research and Innovation, and Senior Director, Community Outreach and Engagement & CHW Training Program in the OSU College of Nursing. Dr. Michelle Greene is an Associate Professor and Director of the Psychology Section in the Department of Pediatrics at Rush Medical College. Research Co-investigators include Dr. Michael Schoeny and Dr. Kousiki Patra from Rush University, Dr. Sarah Keim and Dr. Mary Lauren Neel from Nationwide Children’s Hospital, and Ms. Julia Berteletti from Klein Buendel. The ezPreemie app will be engineered by Klein Buendel’s Creative Team.

Vacteens: A Web App to Boost HPV Vaccine Uptake

Vacteens: A Web App to Boost HPV Vaccine Uptake

Dr. W. Gill Woodall, Klein Buendel Senior Scientist, and his coauthors published the results of the Vacteens Project in the online journal, Frontiers in Digital Health.

The uptake of HPV vaccine in the United States remains lower than preferred by health authorities, particularly for young adolescents, when immunogenic response to the vaccine is strongest. Potential parental barriers to low vaccine uptake include confusion, uncertainty, and misinformation about HPV vaccine schedule, safety, and effectiveness. Dr. Woodall and his collaborators believe that parental barriers to HPV vaccination may be addressed by digital interventions, such as web apps, that are tailored to their concerns.

The Vacteens Project project tested a web app for educating parents. The study was conducted with 82 parent-adolescent (daughter) pairs recruited from in nine pediatric clinics in New Mexico. It tested whether digital information delivered to parents in a community setting may be an effective way to help reach HPV vaccine uptake goals in the United States. Diffusion of Innovations Theory principles were used to guide the development of the Vacteens/Vacunadolescente mobile app in English and Spanish.

Parents were randomized to receive either the Vacteens/VacunaAdolescente mobile web app or the usual and customary online HPV vaccination pamphlet from the U.S. Centers for Disease Control and Prevention (CDC). Parents completed surveys at baseline and month 3, and child vaccine records were collected at month 12. Vaccine uptake results from the study found that parents who received the Vacteens/VacunaAdolescente web app were more likely to have their daughters vaccinated than parents in the control condition. Study methods, results, and limitations are detailed in the online publication.

This research was funded by a grant from the Patient-Centered Outcomes Research Institute (PCORI) to the University of New Mexico (#1511-33018; Dr. W. Gill Woodall, Principal Investigator). Dr. Woodall’s collaborators include Dr. Greg Zimet from Indiana University, Dr. Alberta Kong, Dr. Lance Chilton, and Dr. Randall Starling from the University of New Mexico, and Dr. David Buller, Jeannyfer Reither, and Dr. Valerie Myers from Klein Buendel.